News

March 13, 2019March 13, 2019

Anti-TNF Alpha Therapy Improves Exercise Capacity After Four Months of Treatment, Study Suggests

News

Anti-TNF alpha therapy is able to significantly restore ankylosing spondylitis patients’ capacity to exercise after a treatment period of four months, a small study suggests. After treatment, patients in the ... Read more

March 6, 2019March 6, 2019

High Levels of C-reactive Protein Can Predict Risk for Future Ankylosing Spondylitis, Study Finds

News

High levels of C-reactive protein, a marker of systemic inflammation, at the onset of back pain can help predict which patients go on to develop ankylosing spondylitis, a study ... Read more

March 6, 2019March 5, 2019

NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research

News

Rare diseases affect about 30 million Americans — roughly the same number as those with type 2 diabetes. Yet only 5 percent of the estimated 7,000 rare diseases known ... Read more

March 4, 2019March 4, 2019

Anti-TNF-Alpha Therapies Linked to Reduced Lumbar Spine Deformities, Study Shows

News

Treatment with anti-TNF-alpha therapies can lead to improved lumbar spine curvature and better clinical outcomes in patients with ankylosing spondylitis, study shows. The study, “Radiologic parameters of ankylosing spondylitis ... Read more

February 27, 2019March 27, 2019

Ankylosing Spondylitis Patients Have Higher Risk of Blood Clots, Study Suggests

News

Ankylosing spondylitis (AS) patients have a more than 50% increased risk of developing blood vessel clots, according to a population-based Canadian study. “Clinicians should have an increased awareness of ... Read more

February 25, 2019February 25, 2019

WODC 2019 Organizers Expect 1,200 to Attend Rare Disease Conference in April

News

The world’s biggest gathering of rare disease researchers, patient groups, pharmaceutical executives, and government officials is planned for April 10–12 in a Washington, D.C., suburb. Some 1,200 people have ... Read more

February 25, 2019February 20, 2019

Vienna to Host RARE2019 Meeting on Rare Diseases

News

About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city early next month for the 2nd International Congress on Advanced Treatments in Rare Diseases. The ... Read more

February 18, 2019February 18, 2019

Plant Compound Emodin Could be Used as Treatment for AS, Study Says

News

Emodin, a plant compound used in traditional Chinese medicine, has potent anti-inflammatory and anti-rheumatic properties that, when combined with autophagy inhibitors, may be a promising therapeutic strategy to alleviate symptoms ... Read more

February 13, 2019February 13, 2019

Tiny RNA Molecule a Potential Diagnostic Biomarker for Ankylosing Spondylitis, Study Says

News

Levels of a tiny RNA molecule, called miR-214, correlate with ankylosing spondylitis disease activity and may be used as a noninvasive biomarker in diagnosing the disease, a study has found. ... Read more

February 11, 2019February 11, 2019

Risk for Dementia Higher in Ankylosing Spondylitis Patients, Study Suggests

News

The risk for developing overall dementia and Alzheimer’s disease dementia is higher in patients with ankylosing spondylitis (AS), according to a nationwide study in South Korea. The study, “Relationship ... Read more

Pin It on Pinterest